RTW Investments’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-3,333
Closed -$382K 103
2022
Q2
$382K Hold
3,333
0.01% 104
2022
Q1
$631K Hold
3,333
0.01% 102
2021
Q4
$1.16M Hold
3,333
0.02% 117
2021
Q3
$1.12M Hold
3,333
0.02% 116
2021
Q2
$2.75M Buy
+3,333
New +$2.58M 0.04% 102

Other funds holding OMIC

RTW Investments's OMIC Position: Q3 2022 in Review

RTW Investments sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q3 2022, closing a stake of 3,333 shares — an estimated $382K sold.

RTW Investments first reported a position in OMIC in Q2 2021 and held it in 5 quarters. The position peaked at $2.75M in Q2 2021. 74 funds tracked by Wall St. Rank hold OMIC as of Q3 2022.

  • RTW Investments reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • RTW Investments sold 3,333 Singular Genomics Systems, Inc. Common Stock shares in Q3 2022, an estimated $382K.
  • RTW Investments first reported a position in Singular Genomics Systems, Inc. Common Stock in Q2 2021 and held it in 5 quarters.
  • RTW Investments's Singular Genomics Systems, Inc. Common Stock position peaked at $2.75M in Q2 2021.
  • 74 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q3 2022.

Based on RTW Investments's 13F filing for Q3 2022, filed 14 Nov 2022.